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ABSTRACT: Identifying and characterizing the enzymes responsible
for an observed activity within a complex eukaryotic catabolic system
remains one of the most significant challenges in the study of biomass-
degrading systems. The debranching of both complex hemicellulosic
and pectinaceous polysaccharides requires the production of α-L-
arabinofuranosidases among a wide variety of coexpressed carbohy-
drate-active enzymes. To selectively detect and identify α-L-
arabinofuranosidases produced by fungi grown on complex biomass,
potential covalent inhibitors and probes which mimic α-L-arabinofur-
anosides were sought. The conformational free energy landscapes of
free α-L-arabinofuranose and several rationally designed covalent α-L-
arabinofuranosidase inhibitors were analyzed. A synthetic route to
these inhibitors was subsequently developed based on a key Wittig−
Still rearrangement. Through a combination of kinetic measurements, intact mass spectrometry, and structural experiments, the
designed inhibitors were shown to efficiently label the catalytic nucleophiles of retaining GH51 and GH54 α-L-arabinofuranosidases.
Activity-based probes elaborated from an inhibitor with an aziridine warhead were applied to the identification and characterization
of α-L-arabinofuranosidases within the secretome of A. niger grown on arabinan. This method was extended to the detection and
identification of α-L-arabinofuranosidases produced by eight biomass-degrading basidiomycete fungi grown on complex biomass.
The broad applicability of the cyclophellitol-derived activity-based probes and inhibitors presented here make them a valuable new
tool in the characterization of complex eukaryotic carbohydrate-degrading systems and in the high-throughput discovery of α-L-
arabinofuranosidases.
■ INTRODUCTION
Carbohydrate-degrading machinery is a fundamentally im-
portant component of the metabolic systems that underpin the
global carbon cycle. Our understanding of these systems is
dependent on an ability to identify the capacities of the
carbohydrate-active enzymes produced by an organism. The
growth of genomic libraries has revealed an expansive world of
carbohydrate-degrading enzymes, of which only a small
fraction have been isolated and probed for catalytic potential.1
Transcriptomic and proteomic experiments comparing the
gene expression and protein secretion patterns of organisms
grown on different substrates have helped to identify the
genetic logic used by these organisms to efficiently degrade
recalcitrant biomass.2 However, the underlying chemical
rationale for these expression patterns remains obscure without
highly detailed experimental work characterizing the role of
each enzyme.
Inspired by the work of Withers3−5 and Wright,6 we have
been developing cyclophellitol-derived activity-based inhibitors
and probes (some aspects of which are reviewed in refs 7−9)
for the rapid detection and identification of specific biomass-
degrading glycoside hydrolases within complex systems. The
potential of cyclophellitol-derived activity-based probes
(ABPs) as tools for the detection and identification of
retaining glycoside hydrolases has been well-established.10
Mimicking the half chair conformation of the enzymatic
transition state, cyclophellitol and cyclophellitol aziridine
derivatives react specifically with the catalytic nucleophile of
a retaining glycoside hydrolase, forming a nonhydrolyzable
ester linkage through a ring-opening addition.11 This general
strategy has been exploited to inhibit and label glycosidases
displaying a variety of specificities including α- and β-D-
glucosidases,12−14 β-D-glucuronidases,15 and α- and β-D-
galactosidases,16,17 among others. Building on this work, we
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have recently reported the synthesis and validation of a
collection of cyclophellitol-derived inhibitors and probes which
specifically label retaining β-D-xylanases and β-D-xylosidases.18
These compounds were able to efficiently attach chemical
handles for the detection and identification of key secreted
xylan-degrading enzymes within an Aspergillus secretome.
Expanding this toolbox to target side-chain removal enzymes
has remained a challenge, not least for furanoside-active
enzymes.
α-L-Arabinofuranoside “side-chains” are commonly found on
both hemicellulosic and pectinaceous plant polysaccharides.
The efficient removal of α-L-arabinofuranose branches
enhances the breakdown of xylan-rich biomass.19 Furthermore,
α-L-arabinofuranosidases are an essential part of the poly-
saccharide utilization loci which ferment arabinan chains in
dietary rhamnogalacturonan I and arabinogalactan within the
human gut.20 Thus, cyclophellitol-derived ABPs and inhibitors
for α-L-arabinofuranosidases could be used to identify the
enzymes responsible for the breakdown of a variety of complex
polysaccharides. However, it is not currently known whether
cyclophellitol derivatives can be effectively extended to target
furanosidases.
No route to the synthesis of covalent inhibitors of α-L-
arabinofuranosidases has previously been identified. The first
synthesis of covalent furanose-configured inhibitors was the
preparation of β-D-arabinofuranosyl and α-L-xylofuranosyl
aziridines reported by Bols et al. in 2003.21 These were
prepared via N−O reduction of cyclopentaisoxazolidines. Due
to the inverted stereochemistry of the electrophilic moiety with
respect to C4 (carbohydrate numbering), this synthetic
strategy cannot be translated to α-L-arabinofuranose analogues,
so new synthetic methodologies are needed to expand the
scope of synthetically accessible furanoside mimics.
We have designed a collection of putative α-L-arabinofur-
anosidase inhibitors and ABPs with different electrophilic traps
and detection tags. Potential inhibitors were analyzed in silico
for their ability to mimic the natural 5-membered ring
structure, stereochemistry, and conformational itinerary of
retaining α-L-arabinofuranosides. These inhibitors and probes
were synthesized following a route inspired by the synthesis of
six-membered cyclophellitol derivatives. Inhibition kinetics
measured with α-L-arabinofuranosidases from glycoside hydro-
lase families 51 and 54 (GH51 and GH54), the two major
families of retaining α-L-arabinofuranosidases, were measured
to validate our predictions. Furthermore, the ability of our α-L-
arabinofuranosidase probes to facilitate the selective detection,
identification, and characterization of active GH51 and GH54
enzymes within the complex mixture of enzymes secreted by
Aspergillus niger was validated. These methods were then
extended to the identification of α-L-arabinofuranosidases
within the secretomes of basidiomycete fungi grown on
complex biomass.
■ EXPERIMENTAL SECTION
All chemicals were purchased from Sigma-Aldrich unless otherwise
specified.
Design and Synthesis of α-L-Arabinofuranose-Configured
Cyclophellitol Derivatives. Detailed protocols for synthesis of
compounds 1 to 23 and their NMR characterization can be found in
the Supporting Information.
Secretome Production. Aspergillus niger strain N402 was grown
as described by Schröder et al.18 with a mixture of 50 mM arabinose,
1% sugar beet arabinan, and 2 mM fructose as the sole carbon source.
Samples were collected, 0.2 μm filtered, and snap-frozen after 5 days.
Samples were stored at −80 °C until being thawed immediately
before use.
The strains Abortiporus biennis BRFM 1215 (A. biennis), Fomes
fomentarius BRFM 1323 (F. fomentarius), Hexagonia nitida BRFM
1328 (H. nitida), Leiotrametes menziesii BRFM 1557 (L. menziesii),
Polyporus brumalis BRFM 958 (P. brumalis), Trametes ljubarskyi
BRFM 957 (T. ljubarskyi) Trametes gibbosa BRFM 952 (T. gibbosa),
and Trametes meyenii BRFM 1361 (T. meyenii) were obtained from
the CIRM-CF collection (International Centre of Microbial
Resources dedicated to Filamentous Fungi, INRA, Marseille, France).
All strains were identified by morphological and molecular analysis of
ITS (Internal Transcribed Spacer) sequences. The strains were
maintained on malt agar slants at 4 °C.
Basidiomycete cultures were grown in 250 mL baffled Erlenmeyer
flasks with 100 mL medium containing 2.5 g L−1 of maltose as a
starter (except for the maltose control condition; 20 g L−1), 1.842 g
L−1 of diammonium tartrate as a nitrogen source, 0.5 g L−1 yeast
extract, 0.2 g L−1 KH2PO4, 0.0132 g L
−1 CaCl2/2H2O and 0.5 g L
−1
MgSO4/7H2O, and as a main carbon source, 15 g L
−1 (dry weight) of
wheat straw (Triticum aestivum) or Wiley-milled aspen (Populus
grandidentata). Cultures were incubated in the dark at 30 °C with
shaking at 120 rpm. The cultures were stopped 10 days after
inoculation and the culture broths (secretomes) were filtered using
0.2 μm poly(ether sulfone) membrane (Millipore) and then stored at
−20 °C until use.
Recombinant Enzyme Production. The coding sequence for
Geobacillus stearothermophilus abfA (GsGH51, GenBank: AAD45520)
was synthesized with E. coli codon optimization and cloned into
pET28a(+) with an N-terminal TEV protease-cleavable 6xhis tag by
GenScript. Following transformation of BL21(DE3) Gold, the
enzyme was produced in an auto induction medium (1% tryptone,
0.5% yeast extract, 25 mM Na2HPO4, 25 mM KH2PO4, 50 mM
NH4Cl, 5 mM Na2SO4, 0.05% glucose, 0.5% glycerol, 0.2% lactose) at
37 °C. The enzyme was purified as described previously22 with an
added overnight treatment with his-tagged TEV protease S219 V23 in
pH 8 Tris-HCl, 5 mM DTT, 1 mM EDTA at RT followed by inverse
histrap purification and desalting into 5 mM Tris-HCl, 1 mM EDTA,
pH 8.0.
Aspergillus niger abfA (AnAbfA, GenBank: CAK43424) and
Aspergillus kawachii abfB (AkAbfB, GenBank: BAB96816) were
produced in P. pastoris X-33. A plasmid encoding AkAbfB in pPICZα
with no purification tag was obtained from professors Takuya Koseki
and Shinya Fushinobu. AnAbfA was synthesized by IDT as a GBlock
and cloned into the vector fragment PCR-amplified from the AkAbfB-
pPICZa plasmid using Gibson assembly.24 The AkAbfB (E221Q)
mutant was generated using the Q5 site-directed mutagenesis kit
(New England Biolabs) with primers designed by the NEBase-
Changer tool.
Plasmid DNA for transformation into P. pastoris was linearized with
SacI and purified using a PCR cleanup kit (Qiagen) using ultrapure
water as the eluent. 100 ng of linearized DNA was electroporated into
80 μL of X-33 electrocompetent cells prepared following the protocol
of Wu and Letchworth.25 Nine colonies from each transformation
were purified on YPD-Zeocin plates, then grown in 5 mL of BMGY
medium. At saturation (OD600 ∼ 20) cells were collected by
centrifugation and resuspended in 5 mL of BMMY medium for
expression screening at 20 °C. The transformant which gave the
highest titer of the target protein with minimal detectable
contamination after 3 daily 0.5% MeOH feedings was grown in 500
mL of BMGY in a 2.5 L baffled shaking flask at 30 °C overnight. The
culture was then cooled to 20 °C and supplemented with 2.5 mL of
100% MeOH each day for 3 days.
The culture supernatant was clarified by centrifugation followed by
0.45 μm filtration. A 500 mL portion of medium was concentrated
using a KrosFlo tangential flow system fitted with a 30 kDa MWCO
mPES filter and then diluted with 9 volumes of 10 mM pH 5 sodium
acetate buffer and concentrated again. Protein was then collected onto
a 5 mL Q sepharose HP column (GE Healthcare), washed with 3 CV
of 50 mM pH 5 sodium acetate buffer, then eluted with a 25 CV
gradient from 0 to 0.5 M NaCl in the same buffer. Fractions from the
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largest UV-active peak were pooled, concentrated to 10−30 mg/mL
using a 30 kDa MWCO centrifugal concentrator (Amicon) and
purified over Superdex 200 (GE Healthcare) into 50 mM sodium
acetate pH 5. Protein-containing fractions were pooled and
concentrated to give a colorless 15−25 mg/mL protein solution.
Approximately 5 mg of protein was then treated with 1000 U of
EndoHf (New England Biolabs) overnight at rt. This was purified
using a 5 mL Q sepharose HP column as above. To prepare the
sample for crystallization, the eluent from Q sepharose was mixed 1:1
with saturated ammonium sulfate and purified over a 1 mL phenyl
sepharose HP column with a 25 CV gradient from 2 M ammonium
sulfate to 0 M ammonium sulfate in 50 mM pH 5 sodium acetate
buffer. Protein-containing fractions were pooled, desalted into 20 mM
sodium acetate pH 5, concentrated to 10−30 mg/mL and frozen at
−80 °C.
Enzyme Visualization with ABP 4. ABP 4 was dissolved in
DMSO to prepare a 10 mM stock solution which was diluted in
ultrapure water. Unless otherwise noted, samples were stained with 10
μM ABP 4 at 37 °C for 30 min at pH 6.5 and proteins were separated
at 200 V using either a precast 4−20% (Bio-Rad) or an 8.75% 1 mm
miniprotean SDS-PAGE gel. Fluorescence was imaged using a
Typhoon 5 laser scanner with the Cy5 laser and filter set. Enzyme
molecular weights were estimated using a Pageruler 10−180 kDa
prestained protein ladder.
Basidiomycete secretomes were buffered with 0.1 volumes of 1 M
NH4OAc pH 5.5. For screening, 17.2 μL of buffered secretome was
mixed with 2.8 μL of 60 μM ABP 4 and incubated for 1 h at 30 °C.
The sample was then supplemented with 2 μL of 10X glycoprotein
denaturing buffer (New England Biolabs), heated to 95 °C for 5 min
and split in half. Each half was mixed with 10 μL of 2x PNGaseF
Mastermix (2X glycobuffer 2, 2% NP-40 containing either 0 or 7.5 U/
μL of PNGaseF) and incubated for 1 h at 37 °C. Samples were then
diluted with 6.7 μL of 4X SDS−PAGE loading dye, heated to 95 °C
for 5 min and 10 μL was separated through a 4−15% Criterion (Bio-
Rad) gel.
For scaled up labeling, 20 μL of 60 μM ABP 4 was added to 100 μL
of buffered secretome and incubated at 30 °C for 1 h. 500 μL of
acetone was then added and the samples were incubated at −20 °C
for 1 h. Precipitate was collected by centrifugation at 10000g for 5 min
at 4 °C. The supernatant was discarded, and the sample was left to air-
dry to minimize residual acetone. The sample was then resuspended
in 20 μL of 1X SDS-PAGE loading dye and heated to 95 °C for 5 min
to dissolve. The entire sample was then separated through a 4−20%
gel.
In Situ Characterization of Secreted Enzymes. The pH
optimum of enzyme labeling was determined by visualization with
ABP 4 using the standard protocol (above) with variable buffer
solutions including a series of McIlvane buffers prepared at 0.5 M
strength (0.28 M citrate, 0.22 M phosphate) from pH 2−7.5 in 0.5
pH unit increments and a series of succinate−phosphate−glycine
(SPG) buffers prepared at 0.5 M strength (62.5 mM succinic acid,
219 mM phosphate, 219 mM glycine) from pH 4−10 in 1 pH unit
increments. Five μL of each buffer was added to 45 μL of A. niger
arabinan secretome immediately prior to ABP addition.
The thermal tolerance of secreted enzymes was assayed at the
inhibition optimum (50 mM pH 6.5 phosphate buffer) by incubating
the A. niger arabinan secretome at temperatures ranging from RT to
95 °C for 1 h. Secretome samples were then rapidly cooled to 20 °C
and enzymes were visualized with ABP 4 using the standard protocol.
Measuring Irreversible Inhibition Kinetics. The kinetics of
enzyme inhibition were measured using a continuous assay26,27 at 25
°C in a 384-well plate with 4-methylumbelliferyl α-L-arabinofurano-
side (4MU-Araf) as substrate. Kinetic measurements were made in
technical quadruplicate. Curve fitting and statistical analysis was
performed using OriginPro graphing software. Enzymes were diluted
in 50 mM sodium phosphate buffer pH 7.0. Substrate was dissolved in
DMSO to give a 100 mM stock which was diluted with ultrapure
water. Putative inhibitors were dissolved in and diluted with ultrapure
water with the exception of inhibitor 3 which was dissolved in DMSO
to give a 50 mM stock, which was diluted with ultrapure water.
Enzyme specific activity was initially assessed by monitoring the
hydrolysis of 50 μM 4MU-Araf in pH 7 phosphate for 10 min.
Michaelis−Menten parameters for the hydrolysis of 4MU-Araf were
estimated by varying the substrate concentration from 4 to 500 μM
and fitting a site-saturation kinetic model (v0/[E]t = kcat[S]0/KM +
[S]0) to the resulting rate vs substrate concentration data
(Supplemental Table 1, Supplemental Figures 1A and 2A). Measure-
ments were made at an excitation wavelength of 390 nm (15 nm
bandwidth) to eliminate primary inner filter effects at substrate
concentrations as high as 500 μM in our assay format (Supplemental
Figure 3). Inhibition kinetics were measured using a substrate
concentration of 100 μM and an excitation wavelength of 360 nm, an
enzyme concentration of 50 ng/mL, and variable inhibitor
concentrations. Each fluorescence vs time curve was fitted with an
exponential decay model (F = F∞(1 − e
−kappt)). The resulting
apparent decay constants were plotted against inhibitor concentration
and fitted with a site-saturation kinetic model with correction for
competition by the substrate using the measured KM value and the
initial substrate concentration (kapp = kinact[I]0/1 + ([S]0/KM) + ([I]0/
KI)).
Intact MS Following Enzyme Labeling. GsGH51 or EndoH-
treated AkAbfB were diluted to 0.1 mg/mL in their respective SEC
elution buffers. Compounds 1, 2, or 6 were added to a final
concentration of 50 μM and incubated for 30 min at rt. The treated
protein samples were diluted with 4 volumes of 1% formic acid, 10%
acetonitrile and 5 μL was injected over an MSPac DS-10 Desalting
Cartridge flowing at 30 μL/min using a NanoAcquity HPLC
(Waters). Following a 5 min wash with 20% acetonitrile, 0.1% formic
acid in water, protein was eluted into a maXis UHR-Tof (Bruker)
with a 10 min gradient from 20 to 55% acetonitrile. The column was
washed for 2 min with 80% acetonitrile and equilibrated for 3 min
with 20% acetonitrile between runs. Following protein signal
integration and baseline subtraction, spectra were deconvoluted
using the maximum entropy algorithm within Compass to calculate
protein mass.
Enzyme Pull-down Using ABP 5. A. niger arabinan secretome
was buffered with 50 mM McIlvane buffer pH 6.5 and then treated
with 0.1 mM inhibitor 2 or DMSO control for 1 h at 37 °C (inhibitor
6 is also suitable for pretreatment, Supplemental Figure 4). Following
this, the secretome was treated with either 20 μM ABP 5 or DMSO
control for 30 min at 37 °C. Biotinylated proteins were pulled down,
digested, and identified as described by Schröder et al.18
Basidiomycete secretome samples were processed without concen-
tration or lyophilization with three modifications to the protocol: first,
protein was precipitated through the addition of 4 volumes of acetone
followed by incubation at −20 °C for 1 h; second, following the initial
strep mag sepharose bead wash with 0.5% SDS, beads were washed
with 2% SDS at 65 °C for 10 min with agitation followed by 2 M urea
and then PBS; and last, peptides liberated through on-bead digest
were modified with TMT0 following the manufacturer’s instructions
prior to LC−MS/MS analysis using an Orbitrap Fusion Tribrid mass
spectrometer (Thermo Scientific). Peptides were identified by
mapping onto the predicted proteomes deduced from genome
sequence of A. biennis BRFM 1778, F. fomentarius BRFM 1823, L.
menziesii BRFM 1781, and T. gibbosa BRFM 1770. For each genome
(to be published elsewhere), CAZymes were annotated as in Lombard
et al., 2014.1 All genome and proteome data are publicly available on
the Mycocosm portal (mycocosm.jgi.doe.gov/mycocosm/home).
Enzyme Crystallization and Diffraction. Crystals of GsGH51
were grown essentially as described by Hövel et al.22 Optimized
crystals were grown by mixing 1.2 μL of protein (10 mg/mL in 5 mM
Tris-HCl pH 8.0) with 0.6 μL of well solution containing 15%
PEG3350, 5% 2-propanol, 0.1 M Tris−HCl pH 7.5, 0.80 M NH4F in
a sitting drop at 293 K (Supplemental Figure 5A). To generate
inhibitor-bound complexes, crystal-containing droplets were supple-
mented with 0.1 μL of 2 mM inhibitor in water and incubated
overnight prior to cryo-protection in well solution supplemented with
12.5% glycerol and flash freezing in LN2.
Initially, crystals of AkAbfB were grown essentially as described by
Miyanaga et al.28 Optimized crystals grew from 0.5 μL of 10 mg/mL
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AkAbfB in 50 mM pH 5 sodium acetate mixed with 0.5 μL of 100
mM Tris−HCl pH 8.0, 200 mM MgCl2, 400 mM NaCl, 20%
PEG6000, 2.5% DMF at 279 K. However, preferential formation of
poor-quality needle clusters and poor diffraction of these crystals led
us to explore other crystallization conditions. EndoH-deglycosylated
AkAbfB or AkAbfB (E221Q) (12 mg/mL in 50 mM sodium acetate
pH 5.0) formed slow-growing isolated crystals when mixed 2:1 with
0.2 M lithium sulfate, 0.1 M sodium acetate pH 4.5, 50% PEG400
(Supplemental Figure 5B). Supplementation with 0.2−0.5 M NaCl
resulted in more rapid crystal growth. To generate inhibitor-bound
complexes, crystals were transferred to mother liquor supplemented
with inhibitor 6 or 2 to a final concentration of 0.2 mM, or saturated
with PNP-Araf (for AkAbfB (E221Q)). Crystals were soaked for 1 h
at RT prior to freezing.
Diffraction data were collected at Diamond Light Source (Harwell,
UK) on beamline I04 and automatically processed using the fast_dp29
(GsGH51), autoPROC30 (AkAbfB-2 and AkAbfB-6), or Xia231
(AkAbfB-PNP-Araf) pipelines. Computation was carried out using
programs from the CCP4 suite32 unless otherwise stated. All crystal
structure figures were generated using Pymol (Schrodinger). Data
collection and processing statistics for all structures are given in
Supplemental Table 2.
Structure Solution and Refinement. Data for GsGH51 bound
to inhibitors 2 and 6 were collected to 1.40 Å. Each structure was
solved by molecular replacement using Phaser33 with the known
structure (PDBID: 1pz3) as the search model. The resulting solution
showed clear density for the bound ligand within the enzyme active
site. Ligand coordinates and dictionaries were generated using
jLigand34 and built into the model using Coot,35 followed by
alternating rounds of manual model building and refinement using
Coot and REFMAC5.36
Data for AkAbfB bound to inhibitors 2 and 6 were collected to 1.47
and 1.86 Å, respectively. Each structure was solved by molecular
replacement using Phaser with the known structure (PDBID: 1wd3)
as the search model. The resulting solution showed clear density for
the bound ligand within the enzyme active site. The structures were
refined, as above, and the same ligand coordinates and geometries
were used.
Data for AkAbfB (E221Q) bound to PNP-Araf were collected to
1.64 Å. The structure was solved by molecular replacement using
Phaser with the AkAbfB-2 complex as the search model. The resulting
structure showed clear density for two PNP-Araf (ligand ID: KHP)
molecules bound to the carbohydrate-binding module. Following
several rounds of manual model building and refinement, partial
density for an additional PNP-Araf molecule, which was modeled at
60% occupancy, became apparent in the active site.
Conformational Analysis. Conformational free energy land-
scapes (FELs) were computed for α-L-arabinofuranose and com-
pounds 1, 2, and 6 using Density Functional Theory-based molecular
dynamics (MD), according to the Car−Parrinello (CP) method.37
Each molecule was enclosed in an isolated cubic box of 12.5 Å × 12.5
Å × 12.5 Å. A fictitious electron mass of 500 atomic units (a.u.) was
used for the CP Lagrangian and a time step of 0.12 fs was used in all
CPMD simulations to ensure that the adiabacity of the fictitious
kinetic energy of the electrons was smaller than 10−5 a.u./atom. The
Kohn−Sham orbitals were expanded in a plane wave basis set with a
kinetic energy cutoff of 70 Ry. Ab initio pseudopotentials, generated
within the Troullier-Martins scheme, were employed.38 The Perdew,
Burke, and Ernzerhoff generalized gradient-corrected approximation39
was selected in view of its good performance40 in previous work on
isolated sugars,41 glycosidases, and glycosyltransferases.42 The
metadynamics algorithm,43 provided by the Plumed 2 plugin,44 was
used to explore the conformational free energy landscape of the
systems, taking as collective variables the pseudorotational phase (φ)
puckering coordinate,45,46 as well as a dihedral angle accounting for
the rotation of the sugar hydroxymethyl group. The energy was
projected into the φ coordinate for representation purposes. Initially,
the height of these Gaussian terms was set at 0.6 kcal/mol and a new
Gaussian-like potential was added every 500 MD steps. Once the
whole free energy space was explored, the height of the Gaussian
terms was reduced to 0.2 kcal/mol to facilitate convergence of the
FEL. The width of the collective variables was set according to their
oscillations in the free dynamics which corresponded to 0.035 and 0.1
rad for φ and the hydroxymethyl dihedral angle, respectively. The
simulations were stopped when energy differences among wells
remain constant, which was further confirmed by a time-independent
free energy estimator.47 The exploration of the phase space was
extended up to 380, 360, 324, and 474 ps for α-L-arabinofuranose,
compound 1, compound 2, and compound 6, respectively. The errors
in the principal minima, taken as a standard deviation (SD) from the
last 200 ps, are below 0.6 kcal mol−1. Conformational FELs computed
using only φ as CV gave very similar results.
The Michaelis complexes of compounds 1, 2, and 6 were modeled
using the crystal structures of the adducts obtained for GsGH51 and
AkAbfB as a reference. In the case of compounds 1 and 2, the
Michaelis complex was reconstructed by removing the covalent bond
between the inhibitor and the nucleophile in the protein structure
bound to inhibitor 2. The amine group was reverted to an aziridine
(compound 2), which was replaced with an oxygen atom to give
compound 1.
Molecular dynamics (MD) simulations were set up employing the
program LEaP included in the Amber suite48 and the ff14SB protein
force field.49 The compounds were parametrized using gaff2.50 The
systems were solvated with explicit TIP3P water molecules.51 They
were neutralized with 31 and 21 sodium atoms for all neutral
compounds in GsGH51 and AkAbfB, respectively. The systems with
protonated compound 2 were neutralized with one fewer sodium
atom (30 and 20 in GsGH51 and AkAbfB, respectively). MD
simulations were performed using Amber16.48 A thermal equilibration
to 300 K was done prior to the equilibration of dynamics in the NPT
ensemble with a production phase of 51 ns for each system. The
SHAKE algorithm, with an integration time step of 2 fs, was used. The
binding free energy of the compounds were obtained by using the
MMPBSA method52 integrated in the Amber suite.
■ RESULTS AND DISCUSSION
Free Energy Landscape of α-L-Arabinofuranose, And
the Conformational Itinerary of Family GH51 and GH54
Retaining α-L-Arabinofuranosidases. To gain insight into
the ability of our potential inhibitors to mimic the natural
conformational preferences of α-L-arabinofuranosides, we
computed the relative energy of all ring conformations of
compounds 1, 2, and 6. α-L-Arabinofuranose was also analyzed
for comparison. The conformational free energy landscape
(FEL) of each molecule was calculated using ab initio
metadynamics and the Cremer−Pople puckering coordinates.
This approach has recently been successful in predicting the
performance of pyranose-like inhibitors.14,18
In contrast to GHs which act on pyranosides (e.g., α/β-
glucosidases53 and α/β-mannosidases54), little is known about
the catalytic conformational itineraries of α-L-arabinofuranosi-
dases. The computed FEL of α-L-arabinofuranose (Figure 1B)
shows that all conformations lie in an energy window of ∼5
kcal/mol. This window is significantly narrower than what is
typical for pyranose compounds (∼15 kcal/mol)41,55 and
shows that most α-L-arabinofuranose conformations are
thermally accessible. The most stable conformation is 1T2.
However, this conformation is not catalytically competent
since the axial 2-OH group creates steric hindrance with the
nucleophile residue located on the “beta” face of the sugar.
Conformations between 2E and 4E, being only ∼2 kcal/mol
higher in energy, feature an equatorial 2-OH, eliminating this
steric hindrance. Thus, the ideal Michaelis complex con-
formation for an α-L-arabinofuranosidase should be between
2E and 4E (shaded region in Figure 1B).
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To determine where on this landscape the observed
conformations of enzyme-bound species lie, we surveyed all
of the conformations of L-arabinofuranose observed within the
active sites of crystallized GH51 and GH54 enzymes. Specific
α-L-arabinofuranosidases have been identified within GH
families 43, 51, 54, and 62, of which only families 51 and 54
follow the anomeric stereochemistry-retaining Koshland
double-displacement mechanism.
The most detailed studies of α-L-arabinofuranosidase
mechanisms have been performed using bacterial GH51
enzymes. Paes et al. obtained the structure of an intact
branched pentasaccharide substrate bound to the active site of
TxAbf, a thermostable GH51 from Thermobacillus xylanilyticus
(PDB ID 2VRQ).56 Hövel et al. reported the crystal structure
of Geobacillus stearothermophilus AbfA (hereafter referred to as
GsGH51) bound to 4-nitrophenyl α-L-arabinofuranoside
(PNP-Araf) (PDB ID 1QW9).57 In both of these Michaelis
complexes, the α-L-arabinofuranose rings were found in the 4E
conformation (Figure 2A). Therefore, similar to observations
with GHs acting on pyranose sugars,53 furanosidases distort
the −1 sugar to a conformation that is preactivated for
catalysis. Thus, the conformational catalytic itinerary for the
rate limiting step of the reaction for GH51 family is expected
to go through an oxocarbenium ion-like E3 conformer to fulfill
the requirement of having C4−O5−C1−C2 planarity.58
Beyond the bacterial GH51 enzymes, there is only one
retaining α-L-arabinofuranosidases which has been crystallized.
The structure of Aspergillus kawachii AbfB (a member of GH54
hereafter referred to as AkAbfB) with arabinose in the active
site (PDB ID 1WD4), displays a product complex ring
conformation of 4E.59 Unfortunately, no Michaelis complex of
this enzyme had been reported to date.
Determination of the Michaelis Complex of AkAbfB.
To complete, and thus compare the conformational itineraries
of the GH51 and GH54 families, we studied AkAbfB as a
model GH54 active site. To observe the Michaelis complex, we
soaked crystals of deglycosylated AkAbfB E221Q in a saturated
solution of PNP-Araf in mother liquor. The resulting 1.64 Å
crystal structure contained 3 PNP-Araf molecules: two full
occupancy molecules bound to the carbohydrate binding
module and a partial occupancy molecule bound in the active
site (Supplemental Figure 6A).
Overall, the Michaelis complex displayed similarity to the
product complex published by Miyanaga et al. in 200459
(Supplemental Figure 6B). O2 formed hydrogen bonds with
the carbonyl oxygen of Q221 and the backbone amide of
D297. O3 formed hydrogen bonds with the backbone amide of
G296 and the carboxylate of D219. The ring oxygen formed a
hydrogen bond with the backbone amide of N222 and O5
formed hydrogen bonds with the carboxylate of D219 and the
backbone amide of N223. The furanose ring was found in a 4E
conformation, stacked against a hydrophobic surface formed
by W206 and the C176−C177 disulfide linkage. The axial
nitrophenyl leaving group pointed out of the active site into a
solvent channel. The electrophilic carbon (C1) was positioned
3 Å away from the amide nitrogen, primed for migration away
from the nitrophenyl leaving group with support from anti
protonation of the glycosidic oxygen by D297, the general
acid/base.
Based on this result, and the general observation of one
itinerary per family (at least for members active on similar
substrates),54 we infer that enzymes within GH54 and GH51
share a common catalytic conformational itinerary (Figure
2A). Following binding in a reactive 4E conformation, the
glycone is predicted to pass through an E3 transition state
conformation to give a 2E glycosyl-enzyme intermediate.
Following exchange of the leaving group with water, the
glycone then passes through a second E3 transition state to
form a lower energy product-bound complex observed in the
low energy E3 −
4T3 region. Therefore, the predicted
conformational itinerary for the two half-reactions is 4E →
[E3]
‡
→
2E (glycosylaton) and 2E → [E3]
‡
→ E3/4T3
(deglycosylation), as shown in Figure 2.
Conformational Analysis of Potential α-L-Arabinofur-
anosidase Inhibitors. Having ascertained the FEL for α-L-
arabinofuranose and the conformational itinerary of retaining
α-L-arabinofuranosidases, we next considered the design and
Figure 1. (A) Graphical representation of the conformations of a 5-
membered ring according to the Cremer−Pople angle ϕ. (B)
Conformational FEL of isolated α-L-arabinofuranose. Conformations
observed in Michaelis complexes of α-L-arabinofuranosidases are
represented with a red star (PDB 2VRQ and 1QW9 for GH51 and
PDB 6SXR, this work, for GH54). The conformational region having
an equatorial O2 is shaded. (C) Conformational FEL of α-L-
arabinofuranose-configured cyclophellitol (1), aziridine (2), and
cyclic sulfate (6).
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synthesis of covalent inhibitors. As discussed above, both
GH51 and GH54 enzymes form Michaelis complexes in the 4E
conformation (red stars in Figure 1B). Therefore, a suitable
covalent α-L-arabinofuranosidase inhibitor should readily
adopt a 4E conformation in which the atom that mimics the
anomeric carbon is similarly accessible for nucleophilic attack
from the beta face of the sugar ring. Computed FELs for
compounds 1, 2, and 6 (Figure 1C) show that conformations
around 4E are energetically favored for 6, whereas 1 and 2
instead prefer conformations in which the 2-OH is axial (in the
1T2 − E2 −
3T2 region). Thus, cyclic sulfate 6 was anticipated
to be a potentially more potent inhibitor than the epoxide (1)
or aziridine (2) for both GH51 and GH54 α-L-arabinofur-
anosidases.
Synthesis of α-L-Arabinofuranose-Configured Inhib-
itors and ABPs. To synthesize α-L-arabinofuranosidase
inhibitors, we took inspiration from the synthesis of six-
membered cyclophellitol derivatives beginning from appropri-
ately functionalized cyclohexene starting materials. α-L-
Arabinofuranose-configured cyclopentene was prepared in
nine steps from commercial methyl α-D-galactopyranoside in
15% yield. The initial installation of a p-methoxybenzylidene
acetal (PMP) at C4 and C6 of methyl α-D-galactopyranoside
(carbohydrate numbering) by treatment with anisaldehyde
dimethylacetal followed by benzylation at C2 and C3 afforded
intermediate 7 in 74% yield over 2 steps (Scheme 1). Selective
opening of the PMP-group in compound 7 with Bu2BOTf and
BH3·THF, followed by nucleophilic substitution of the primary
alcohol with iodine and Vasella fragmentation with activated
zinc powder afforded intermediate 10 in 60% yield over three
steps. We were able to scale this process up to 56 mmol with
moderate yields. Wittig olefination of aldehyde 10 and
subsequent ring-closing metathesis (RCM) with second-
generation Grubb’s catalyst afforded 12. The PMB group
was then selectively removed with DDQ and intermediate 14
was obtained in 80% yield over two steps by subsequent
alkylation with freshly synthesized Bu3SnMeI. The key step, a
Wittig−Still rearrangement of intermediate 14 with n-BuLi at
−78 °C, afforded the desired cyclopentene 15 in 68% yield.
Figure 2. (A) Koshland double-displacement mechanism employed by retaining α-L-arabinofuranosidases, as proposed for GH51 and GH54,
showing the conformational reaction itinerary including the (left-to-right) Michaelis complex, transition state 1, covalent substrate-enzyme
intermediate, transition state 2, and the hydrolyzed product. (B) Chemical structures of putative α-L-arabinofuranosidase inhibitors 1, 2, 3, and 6
and ABPs 4 and 5.
Scheme 1. Synthesis of L-Arabinofuranose-Configured
Cyclopentene 15a
aReagents and conditions: (a) (1S)-(+)-10-camphorsulfonic acid,
CH3CN, 50 °C, 300 mbar, 2.5 h; (b) BnBr, NaH, TBAI, DMF, 0 °C,
rt, 18 h, 74% over two steps; (c) BH3·THF, Bu2BOTf, DMF, 0 °C, 15
min, 90%; (d) I2, TPP, THF, reflux, 3 h, 79%; (e) activated Zn
powder, THF, 35 °C, 2 h, 84%; (f) Ph3PCH3Br, n-BuLi, THF, −78 to
−20 °C for 1 h, then rt, 18 h, 73%; (g) Grubb’s II cat., DCM, reflux,
18 h, 90%; (h) DDQ, DCM, 0 °C, rt, 2 h, 86%; (i) Bu3SnMeI, KH,
dibenzo-18-crown-6, THF, 0 °C, rt, 18 h, 91%; (j) n-BuLi, THF, −78
°C to rt, 18 h, 68%.
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The first step toward the designed α-L-epoxide and α-L-
aziridine compounds was stereoselective epoxidation of
cyclopentene 15 (Scheme 2). We rationalized that treatment
of cyclopentene 15 with m-CPBA would lead to predominant
β-L-epoxidation where the neighboring primary alcohol would
play a directing role by hydrogen bonding with m-CPBA.
Indeed, m-CPBA epoxidation at 50 °C overnight resulted in a
separable 3.4:1 mixture of β-L- and α-L-epoxides in 62% yield.
Cooling the mixture to 4 °C slowed the reaction, and after 4
days, we observed a β-L to α-L ratio of 4.3:1, with a higher
reaction yield (91%). To synthesize the α-L-epoxide selectively,
cyclopentene 15 was benzylated and subjected to epoxidation
with m-CPBA. Although the β-L to α-L ratio was improved to
1:2, it resulted in a chromatographically inseparable mixture.
Thus, α-L-arabinofuranose-configured epoxide 1 was obtained
by hydrogenation of partially benzylated 17 with Pearson’s
catalyst.
Taking advantage of the C2 and C4 stereochemistry of 18,
direct aziridination aided by steric hindrance of the vicinal
protecting groups was attempted first. No aziridination was
observed with 3-amino-2-(trifluoromethyl)quinazolin-4(3H)-
one (Q-CF3) as nitrogen donor and phenyliodine(III)
diacetate (PIDA) to form the reactive acetylated quinazoli-
none.60 O-(2,4-Dinitrophenyl)hydroxylamine (DPH) and a
ruthenium catalyst also gave no aziridination.61 Hypothesizing
that the alkene is not accessible enough due to the
conformation of cyclopentene and/or steric hindrance of the
benzyl groups, we pursued aziridine 2 by benzylation of the
primary hydroxyl of epoxide 16 and subsequent SN1 ring
opening with sodium azide. This afforded two separable
regioisomers in 1:2 (21:22) ratio with 77% yield (Scheme 3).
Hydroxyls of 21 and 22 were first tosylated and subsequently
treated with triphenylphosphine (TPP) and diisopropylethyl-
amine (DIPEA) at 60 °C to obtain benzylated aziridine 23 in
28% yield over two steps. Aziridine 2 was obtained after
deprotection under Birch conditions (sodium and tert-butanol)
with an overall yield of 11% from epoxide 16. To synthesize
ABPs, aziridine 23 was alkylated with 8-azidooctyl triflate.
Following Birch deprotection, amino-octylaziridine 3 was
obtained in 54% yield over two steps. Aziridine 3 was then
coupled with either Cy5-OSu or biotin-OSu esters in the
presence of DIPEA to afford ABPs 4 and 5 following reverse-
phase HPLC-MS purification.
The synthesis of irreversible α-L-arabinofuranose configured
cyclic sulfate 6 (Scheme 4) started with the oxidation of 18
with a mixture of NaIO4 and RuCl3·3H2O affording exclusively
cis-α-L-diol 25 in 48% yield. Diol 25 was then treated with
thionyl chloride and trimethylamine, and the sulfite mixture
was then further oxidized with NaIO4 and RuCl3•3H2O to
give cyclic sulfate 26. This was deprotected using Pearson’s
catalyst to afford final cyclic sulfate 6 in 24% yield from 18.
Inhibition of Recombinant α-L-Arabinofuranosidases.
With 1, 2, and 6 in hand, we first assessed the potency of these
putative inhibitors against their intended targets. To test the
effectiveness of each inhibitor, inhibition kinetics were
measured with a collection of recombinantly produced
retaining α-L-arabinofuranosidases including G. stearothermo-
philus GH51 (GsGH51, a bacterial enzyme from GH51), A.
niger AbfA (AnAbfA, a fungal enzyme from GH51), and A.
Scheme 2. Synthesis of Epoxidesa
aReagents and conditions: (a) m-CPBA, DCM, 50 °C, 18 h, 62%,
3.4:1 of 16:17; (b) m-CPBA, DCM, 0 °C, 4 days, 91%, 4.3:1 of 16/
17; (c) m-CPBA, DCM, 50 °C, 18 h, 62%, 1:2 of 19/20; (d) H2,
Pd(OH)2, MeOH, 18 h, 50%.
Scheme 3. Synthesis of α-L-Aziridines 2−5a
aReagents and conditions: (a) BnBr, NaH, TBAI, DMF, rt, 18 h, 78%;
(b) NaN3, LiClO4, DMF, 100 °C, 18 h, 77%; (c) TsCl, DMAP, TEA,
DCM, 0 °C, 18 h, 50%; (d) TPP, DIPEA, THF/H2O, reflux, 1.5 h,
56%; (e) Li, NH3, −60 °C, 1 h, 66%; (f) 8-azidooctyl triflate, DIPEA,
DCM, 0 °C to rt, 18 h, 57%; (g) Na, NH3, t-BuOH, −60 °C, 1 h,
95%; (h) Cy5-Osu or biotin-OSu, DIPEA, DMF, 18 h, 4: 56% and 5:
19%.
Scheme 4. Synthesis of Cyclic Sulfate 6a
aReagents and conditions: (a) NaIO4, RuCl3·3H2O, EtOAc/CH3CN/
H2O, 0°C, 3 h, 48%; (b) (i) SOCl2, Et3N, DCM, 0 °C, 30 min, (ii)
NaIO4, RuCl3·3H2O, EtOAc/CH3CN/H2O, 0 °C, 3 h, 51%; (c) H2,
Pd(OH)2, MeOH, 18 h, 24%.
Journal of the American Chemical Society pubs.acs.org/JACS Article
https://dx.doi.org/10.1021/jacs.9b11351
J. Am. Chem. Soc. 2020, 142, 4648−4662
4654
kawachii AbfB (AkAbfB, a fungal enzyme from GH54). Initial
overnight incubations of each enzyme with compounds 2 and
6 resulted in the complete loss of activity, while no loss of
activity was observed with compound 1. Intact MS of GsGH51
and AkAbfB treated with each compound confirmed complete
1:1 labeling with compounds 2 and 6, and no labeling with
compound 1 (Supplemental Figures 7 and 8).
As predicted by our conformational analysis, compound 6 is
a potent inhibitor of retaining α-L-arabinofuranosidases.
Inhibitor 6 reacted rapidly with the catalytic nucleophile of
both AkAbfB and AnAbfA with a kinact well above 1 min
−1
(estimated from the limited speed of our assay). However, the
lack of any apparent nonlinearity in the kapp vs [I] curve for
either AkAbfB or AnAbfA suggested poor initial binding
(Supplemental Figures 1 and 2). In spite of this, inhibitor 6 has
a performance constant of 170 M−1 s−1 with AnAbfA and 250
M−1 s−1 with AkAbfB (Table 1), comparable to the inhibition
of TmGH1 with cyclophellitol reported by Gloster et al.11
(290 M−1 s−1).
Contrary to our prediction, compound 2 also proved to be a
potent inhibitor of both AkAbfB and AnAbfA, having
performance constants only 8-fold and 4-fold lower than
inhibitor 6 with AkAbfB and AnAbfA, respectively (Table 1).
In contrast to inhibitor 6, inhibition kinetics with inhibitor 2
provided evidence of stronger initial binding in both enzyme
active sites, having KI values of 0.1−0.3 mM. The addition of
an alkyl chain to generate inhibitor 3 did not hinder initial
binding with either AnAbfA or AkAbfB and caused only a 4-
fold reduction in kinact, demonstrating that alkylation of the
aziridine is a well-tolerated method for generating α-L-
arabinofuranosidase ABPs.
The lack of measurable inhibition kinetics for compound 1
allowed us to establish a maximum value for the putative
inhibitor’s performance constant (kinact/KI) of approximately
0.1 M−1 s−1 based on the length and sensitivity of the assay and
the maximum inhibitor concentration tested (Supplemental
Figures 1 and 2). Similarly, no reversible inhibition was
observed at concentrations as high as 0.25 mM. Together,
these results confirmed that, as predicted from our conforma-
tional analysis, compound 1 was not an inhibitor of retaining
α-L-arabinofuranosidases at concentrations up to 0.25 mM.
Structural Analysis of Inhibitors 2 and 6 Bound to α-
L-Arabinofuranosidases. To determine whether inhibitors 2
and 6 both interact with α-L-arabinofuranosidases as effective
α-L-arabinofuranose mimics, we sought to understand how the
inhibitors bind to the enzyme active site. Soaking GsGH51
with inhibitors 2 and 6 overnight at room temperature resulted
in the formation of full occupancy covalent complex between
E294, the known catalytic nucleophile, and each inhibitor
(Figure 3A,B). These structures are similar to the complexes
reported by Hövel et al.57 They reported a covalent substrate-
enzyme intermediate trapped in a 2E conformation (PDB ID
1PZ2); however, poor electron density at the anomeric center
of the Hövel structure limits the confidence with which this
ligand conformation can be interpreted. Nevertheless, it is clear
that the structure of the active site varies between the Hövel
complexes and the complexes with inhibitors 2 and 6 that we
obtained (Supplemental Figure 9).
Complexes with both inhibitors 2 and 6 are characterized by
the positioning of the E294 side chain away from R69, toward
the unliganded (PDBID: 1PZ3) position of Y246, which, in
place of a hydrogen bond to the ring oxygen of α-L-
arabinofuranose, forms a hydrogen bond with O5 of the
inhibitor (carbohydrate numbering). While the resulting
displacement of Y246 has only a minimal impact on the
protein structure when bound to inhibitor 6, binding to
inhibitor 2 results in the dramatic displacement of Y246, and
consequently W298 and N302, creating sufficient space for the
side chains of I356 and L318 to pack into a different position
and for a glycerol molecule to bind. The presence of the bulky
charged sulfate group following reaction with inhibitor 6
appears to repel E175, the general acid/base residue, displacing
H244 and, through steric interactions, the S215-R218 loop. To
investigate whether E175 is interfering with the binding of
inhibitor 6, we simulated the Michaelis complex of inhibitor 6
with the E175A and E175G mutants, and calculated the
binding energy of 6. Binding energy was less favorable with
either mutant (+4 kcal/mol for E175A and +8 kcal/mol for
E175G). We interpret this as indicating that the displacement
of E175 likely occurs following the reaction of the cyclic sulfate
with the covalent nucleophile. We speculate that the observed
active site rearrangement occurs following the addition
reaction and is not relevant to initial inhibitor binding. Overall,
while inhibitors 2 and 6 both bind in a manner mimicking the
cognate substrate of GsGH51, their labeling of the catalytic
nucleophile appears to induce significant rearrangement of the
active site structure.
Interestingly, following reaction with the catalytic nucleo-
phile, the conformation of inhibitor 2, but not inhibitor 6,
appears to represent the glycone conformation expected of the
glycosyl enzyme intermediate. Reacted inhibitor 2 was found
in the 2E conformation, forming hydrogen bonds from O2 to
N174, from O3 to N74 and E29, and from O5 to Q351 and
Y246. Inhibitor 6 formed the same complement of ligand-
protein interactions but sat in the active site in an unusual E1
conformation. We attribute this to a combination of electro-
static repulsion and steric bulk pushing the sulfate group out of
the active site, promoting an extended conformation for the
bonds connecting Oε1 of E294 to the sulfate group.
To generate covalent GH54 complexes, we soaked crystals
of AkAbfB with 0.2 mM of inhibitor 2 or 6 for 1 h. Both
inhibitors bound to E221 in almost identical positions and
conformations (Figure 3C,D), forming hydrogen bonds from
O2 to G296 and the sulfur of M195, from O3 to N297 and
Table 1. Kinetic Parameters for Covalent Inhibition of
AnAbfA and AkAbfB by α-L-Arabinofuranosidase
Compounds 1, 2, 3, and 6a
compd KI (μM) kinact (min
−1) kinact/KI (s
−1 M−1)
AnAbfA (GH51)
1 nd nd <0.1
2 140 ± 20 0.33 ± 0.02 39
3 210 ± 30 0.09 ± 0.01 7.1
6 nd nd 160 ± 20
AkAbfB (GH54)
1 nd nd <0.1
2 320 ± 50 0.54 ± 0.07 28
3 320 ± 40 0.12 ± 0.01 6.2
6 nd nd 240 ± 30
aFor reactions with compound 6, it was not possible to obtain distinct
kinact and KI parameters; only the combined kinact/KI parameter
determined from the slope of the kapp vs [I] curve is shown for these
cases. nd: not determined.
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D219, and from O5 to D219 and N223. The interaction
between the ring oxygen and N222 found in the product
complex (PDBID: 1WD4) cannot be formed, but the axial
amine presents an additional hydrogen bond with D297, the
general acid/base. In contrast to the complex with GsGH51,
the interactions between both inhibitors 2 and 6 and the active
site of AkAbfB cause no significant change in the protein
structure. The active site appears to be sufficiently open to
accommodate the sulfate of inhibitor 6 without any steric
clashes. Thus, we believe that these complexes are good
representations of the glycosyl-enzyme intermediate structure.
The ring in each covalent complex is found in the 2E
conformation. This consensus conformation represents a 1.2 Å
migration of C1 from its position in the AkAbfB Michaelis
complex toward E221 coupled with a ∼15° axial rotation of the
ring around C3 (Supplemental Figure 10).
Probing the A. niger Arabinan Secretomes with ABP
4. Building on the success of inhibitors 2 and 3 as covalent
inhibitors of both GH51 and GH54 α-L-arabinofuranosidases,
we set out to detect and identify α-L-arabinofuranosidases
within complex fungal secretomes. As a validation of this
approach, we chose to work with the well-studied secretome of
A. niger grown on arabinan.
Multiple α-L-arabinofuranosidases have been purified from
the A. niger secretome and characterized.62−64 These include
AnAbfA, the fungal GH51 that we produced recombinantly,
and AnAbfB, a GH54 enzyme 98% identical to AkAbfB. Thus,
we hypothesized that our ABPs could be used to identify the α-
L-arabinofuranosidases that are produced by A. niger in
response to a specific carbon source.
The treatment of the A. niger arabinan secretome with
inhibitor 2 resulted in the complete loss of activity against
4MU-Araf, suggesting that all of the α-L-arabinofuranosidase
activity in our secretome sample could be attributed to
retaining glycosidases.
Visualization of α-L-arabinofuranosidases using ABP 4
revealed two distinct bands, one running at ∼105 kDa and
the other running at ∼65 kDa (Figure 4A). Deglycosylation
with PNGaseF under denaturing conditions resulted in a shift
of the 105 kDa band down to ∼70 kDa and a shift of the ∼65
kDa band down to ∼60 kDa. Based on similar results obtained
with recombinant AnAbfA and AkAbfB, we hypothesized that
the top band was one of the A. niger GH51 enzymes and the
bottom band was AnAbfB, the only A. niger GH54 enzyme.
Investigations of the effects of pH on labeling efficiency
revealed that AnAbfB reacted with our probe efficiently over a
pH range (2−9), which extended further into the acidic range
than the GH51 enzyme (5−8) (Supplemental Figure 11).
Notably, both enzymes were labeled optimally at pH 6.5−7,
which is significantly above pH 4, at which the enzymes are
optimally active. While similar discrepancies between optimal
hydrolytic and inhibition pH have been reported previ-
ously,15,18 the difference of 2.5−3 pH units that we observed
is unusually large, suggesting that the optimal protonation
states of active site residues for inhibition by compound 2 and
glycoside hydrolysis are different.
This is supported by the trends observed in the binding
energies calculated for the modeled Michaelis complexes of
inhibitor 1, 2, and 6 in the GH51 and GH54 active sites
(Supplemental Figures 12 and 13). The binding energy of
Figure 3. Crystal structures of complexes between inhibitors 2 (B, D, green) and 6 (A, C, purple), and GsGH51 (A, B, blue) and AkAbfB (C, D,
yellow). 2F0 − Fc electron density is shown for both the ligand and the catalytic nucleophile as a gray mesh contoured at 2σ. The polypeptide is
shown in cartoon form with active site residues shown as sticks. Apparent hydrogen bonding interactions are shown as dotted yellow lines.
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inhibitor 2 was calculated in 3 different situations in each
active site: deprotonated inhibitor 2 with protonated acid/base
residue, protonated inhibitor 2 with protonated acid/base
residue, and protonated inhibitor 2 with deprotonated acid/
base residue. Protonated compound 2 (with the optimal acid/
base residue protonation) binds better than all the other
compounds in both enzymes (Supplemental Figure 14); thus,
not requiring the donation of a proton from the general acid/
base residue for the reaction to take place. Also, the
importance of the protonation state of the acid/base residue
seems to be different in both enzymes. GH54 with an extended
acidic range of labeling efficiency seems to have similar binding
energies with either the protonated or deprotonated general
acid/base; whereas in GH51, 2 binds much better when it is
deprotonated, explaining the more restricted pH range of
labeling efficiency.
To investigate the thermal stability of arabinofuranosidases
within the A. niger arabinan secretome, we preincubated the
Figure 4. Activity-based protein profiling of fungal secretomes with ABPs 4 and 5. (A) Fluorescence imaging of the secretome isolated from A. niger
grown on arabinan, stained with ABP 4, and treated with (PNG+) or without (PNG-) PNGaseF under denaturing conditions prior to separation
on an 8.75% SDS-PAGE gel. L indicates the ladder lanes. (B) Label-free quantification of the top eight proteins pulled down from the A. niger
arabinan secretome. For each protein (identified by NRRL3 number and common name), integrated peptide intensity is plotted for nonconflicting
peptides from the pull-down with ABP 5 (PD, black), from the total secretome (TS, blue), and from the pull-down with ABP 5 following
pretreatment with inhibitor 2 (PT, red). Error bars represent the standard deviations of three measurements. (C) Cy5 fluorescence (red) and
Coomassie staining (green) of basidiomycete secretomes following staining with ABP 4 and acetone precipitation. L indicates the ladder lane. The
BRFM number for the strain from which the secretome was isolated is given above each lane. (D) Plot of total spectral counts in the pull-down
sample vs the ratio of spectral counts in the pull-down sample to spectral counts in the total secretome for all of the proteins for which at least 2
peptides were observed with an FDR of 1% in the pull-downs from L. menziesii (BRFM 1557), F. fomentarius (BRFM 1323), T. gibbosa (BRFM
952), and A. biennis (BRFM 1215). Points corresponding to GH51 enzymes are shown in orange, points corresponding to other putative retaining
GH enzyme with peptide molecular weights >90 kDa are shown in red. The labels shown include the species abbreviation and the Mycocosm
amino acid sequence number.
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secretome at various temperatures for 1 h prior to visualization
with ABP 4. This revealed enzyme recovery from surprisingly
high temperature treatments (Supplemental Figure 15A,C).
Both enzymes were stable up to 60 °C. Increasing the
temperature to 65 °C resulting in a complete loss of GH54
staining and raising it to 67 °C resulted in a complete loss of
both GH51 and GH54 labeling, suggesting complete
denaturation. However, increasing the preincubation temper-
ature beyond 67 °C resulted in a partial recovery of GH54
staining. Preincubation at 86.5 °C resulted in a ∼50% recovery
of fluorescence intensity relative to the RT control (estimated
by band integration using ImageQuant software (GE)). To
determine the role of disulfide bonding in the stability AbfA
and AbfB and the apparent refolding of AbfB, we repeated the
experiment with 5 mM DTT (Supplemental Figure 15B,C).
The addition of DTT had minimal impact on the apparent
stability of AbfA, yet significantly reduced the apparent stability
of AbfB, causing a near complete loss of staining at 56 °C. This
suggests that the four disulfide bonds found in the structure of
AkAbfB (conserved in AnAbfB) are critical for enzyme
stability, but that disulfide bonds are not important for AbfA
stability. Enzyme recovery from elevated temperatures was
reduced, but still occurred in spite of the reduction of disulfide
bonds.
To determine whether the recovery of AbfB staining was
genuinely related to the recovery of active enzyme, we
measured hydrolytic activity of the DTT treated secretome
samples toward 4MU-Araf (Supplemental Figure 15D). This
confirmed that the loss of AbfB staining at 56 °C correlated
with an ∼80% reduction in activity and that the subsequent
loss of AbfA staining at 67 °C corresponded with a complete
loss of activity. At higher temperatures we observed a small
recovery of activity which correlated with the recovery of AbfB
staining. Thus, visualization with ABP 4 facilitates the
identification of thermally resilient enzymes within the context
of their native fungal secretome.
Identification of A. niger α-L-Arabinofuranosidases by
Pull-down with ABP 5. Based on molecular weight and
glycosylation state, we hypothesized that the enzymes stained
by ABP 4 were a GH51 and a GH54. However, it was not clear
which of the GH51 enzymes produced by A. niger was
expressed. A previous report has identified AbfA, AbfB, and
AbfC as the major α-L-arabinofuranosidases produced by A.
niger in response to growth on arabinan-rich sugar beet
pectin.62 The genome of A. niger encodes two other GH51
genes: abfD, which is not expressed during growth on arabinan,
and the more recently identified abfE, for which expression has
not been investigated in response to arabinan.
On-bead digestion of proteins pulled down following
treatment of the secretome with ABP 5 yielded peptides
from AbfB (GH54, GenBank: CAK42333), AbfA (GH51,
GenBank: CAK43424), and AbfE (GH51, GenBank:
ACE00420) as well as a small collection of other proteins
not known to be α-L-arabinofuranosidases (Figure 4B). We did
not observe AbfC or AbfD in our analysis of the pull-down
total secretome, indicating that these were not produced in our
culture. Preincubation of the secretome with inhibitor 2
followed by treatment with ABP 5 and pull-down significantly
reduced signal for peptides from AbfA, AbfB, and AbfE without
causing a significant reduction in signal for any other detected
proteins. Although we cannot exclude that ABP 5 has specific
targets beyond arabinofuranosidases that are incapacitated by
inhibitor 2, these results reveal the utility of ABP 5 in activity-
based protein profiling to identify and annotate retaining
arabinofuranosidases from secretomes derived from micro-
organisms grown on arabinofuranose-containing biopolymers.
Screening Basidiomycetes for α-L-Arabinofuranosi-
dase Production. Following the success of the detection and
identification of A. niger α-L-arabinofuranosidases, we applied
ABPs 4 and 5 to the detection and identification of α-L-
arabinofuranosidases secreted by basidiomycetes grown on
complex biomass. We selected a sampling of eight
basidiomycetes, all known to be proficient biomass-degrading
fungi (Supplemental Table 3). The genomes of these fungi
encode no apparent GH54 enzymes and either one (A. biennis
and T. gibbosa) or two apparent GH51 enzymes. To identify
the GH51(s) produced during growth on complex biomass,
these fungi were cultured on maltose, aspen pulp, or wheat
straw for 10 days prior to secretome collection.
α-L-Arabinofuranosidases were visualized by treatment of
secretome samples with ABP 4 at pH 5.5, 30 °C for 1 h
followed by denaturation, deglycosylation, and separation on
SDS−PAGE. Glycoproteins migrating at 70−80 kDa were
observed in secretomes collected from T. gibbosa (the top
biomass digestion-enhancing strain identified in a sampling of
French biomass-degrading fungi65), F. fomentarius (a white-rot
fungus which grows on hardwood trees66), and L. menziesii and
A. biennis (both known to be effective in biomass pretreat-
ment67,68) when grown on aspen pulp (Supplemental Figure
16A). T. gibbosa and L. menziesii secretomes gave the same
band following growth on wheat straw while the secretomes of
A. biennis and F. fomentarius did not (Supplemental Figure
16B). T. gibbosa, F. fomentarius, and A. biennis did not produce
any apparent α-L-arabinofuranosidase when grown on maltose.
However, surprisingly, L. menziesii did. Coomassie staining
showed very little total protein present in any of the secretome
samples (Supplemental Figure 16C,D), demonstrating the
remarkable sensitivity of ABP 4.
Based on these results, T. gibbosa, L. menziesii, A. biennis, and
F. fomentarius were selected for follow-up studies. Staining 100
μL of secretome followed by acetone precipitation gave much
higher band intensity compared to the effective loading of ∼2.8
μL in the screening experiment. This revealed a collection of
1−3 bands running between 55 and 130 kDa (Figure 4C and
Supplemental Figure 17). Coomassie staining of the same gel
revealed a broad range of bands, few of which appeared to
comigrate with the bands detected by visualization with ABP 4
(Figure 4C).
Bands stained with ABP 4 in these samples were identified
by pull-down using the same protocol as for the A. niger
secretome, but with an added 10 min wash of the beads with
2% SDS at 65 °C to more strictly eliminate any proteins
nonspecifically bound to the beads. Comparing proteomic
analyses of the secretome and pull-down samples, the vast
majority of proteins found within the secretome were rendered
undetectable by our washing protocol. In spite of this, the
proteins confidently observed (at least two unique peptides
identified with an FDR of 1%) were still predominantly not
enzymes phylogenetically related to known α-L-arabinofur-
anosidases. Considering the abundance of GH7 enzymes
apparent in the total secretome and in the pull-down, and the
apparent staining of the same enzymes by ABP 4 (∼50−60
kDa bands in Figure 4C), we believe that many of these hits
represent nonspecific labeling of abundant species within the
secretome (e.g., GH7 enzymes Lmen|932922, Ffom|431808,
and Tgib|1002594).
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Thus, we combined the metrics of total spectral counts from
the pull-down (SC(PD), a rough measure of abundance) and
the ratio of spectral counts from the pull-down to spectral
counts from the digestions of the total secretome (SC(PD)/
SC(TS), a rough measure of selectivity) to give the plot shown
in Figure 4D. Three GH51 enzymes (JGI ProtIDs Lmen|
915930, Tgib|1320025, and Ffom|1458192) appear as distinct
targets of ABP 5 with elevated SC(PD) and SC(PD)/SC(TS).
These GH51 enzymes had masses correlated with the masses
of the most intense bands observed by visualization with ABP
4 (those between 70 and 100 kDa). A single GH51 enzyme in
the same mass range from A. biennis (Abien|540325) was
detected in the pull-down sample. However, the signal was
weak, with only 4 spectral counts detected.
Based on the limited number of hits in the pull-down
samples with predicted molecular weights above 90 kDa, we
believe that the higher molecular weight bands (100−120
kDa) observed in the SDS−PAGE of secretomes from T.
gibbosa, A. biennis, and F. fomentarius are GH3, GH31, or
GH35 enzymes. Most of these enzymes were observed with
poor SC(PD) and SC(PD)/SC(TS) values (red dots in Figure
4D), however a single GH3 enzyme (Tgib|1466933) appeared
to be a target of ABP 5. While this may represent substrate
flexibility within these GH families, it remains to be
determined whether these enzymes display significant α-L-
arabinofuranosidase activity.
■ CONCLUSIONS
The discovery of the mechanism-based covalent α-L-
arabinofuranosidase inhibitors 2 and 6 expand the library of
tools available for the characterization of enzymes expressed
during plant biomass degradation. The unexpectedly high
efficiency of inhibitors 2 and 3 provided a platform on which
ABPs for α-L-arabinofuranosidases could be synthesized. The
potential of ABPs 4 and 5 in the discovery, identification, and
characterization of α-L-arabinofuranosidases from fungal
secretomes grown on both arabinose-rich biomass and
complex woody biomass has been demonstrated. We envision
that the ability to efficiently screen samples of interest for levels
of multiple active α-L-arabinofuranosidases will facilitate and
accelerate a variety of applications including enzyme discovery,
bioprocess monitoring, and the investigation of plant-pathogen
interactions.
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Teor̀ica i Computacional (IQTCUB), Universitat de Barcelona,
08028 Barcelona, Spain; Institucio ́ Catalana de Recerca i
Estudis Avanca̧ts (ICREA), 08020 Barcelona, Spain;
orcid.org/0000-0003-1477-5010; Email: c.rovira@ub.edu
Herman S. Overkleeft − Leiden Institute of Chemistry, Leiden
University, 2300 RA Leiden, The Netherlands; orcid.org/
0000-0001-6976-7005; Email: h.s.overkleeft@
lic.leidenuniv.nl
Gideon J. Davies − York Structural Biology Laboratory,
Department of Chemistry, The University of York, York YO10
5DD, U.K.; orcid.org/0000-0002-7343-776X;
Email: gideon.davies@york.ac.uk
Authors
Nicholas G. S. McGregor − York Structural Biology
Laboratory, Department of Chemistry, The University of York,
York YO10 5DD, U.K.
Marta Artola − Leiden Institute of Chemistry, Leiden University,
2300 RA Leiden, The Netherlands; orcid.org/0000-0002-
3051-3902
Alba Nin-Hill − Departament de Quıḿica Inorgaǹica i
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